Two clinical studies open up new perspectives for the functional use of Montmorency tart cherries in inflammation prevention and metabolic health management.
Until recently, tart cherries – particularly the Montmorency variety – were mainly known in the sports world for their benefits on muscle recovery.
Today, however, new clinical studies reveal their potential in counteracting systemic inflammation and supporting metabolism.
In two recent studies conducted on healthy subjects, researchers investigated the effect of supplementation with concentrated tart cherry extracts on certain biomarkers related to oxidative stress and inflammation.
The first study – a randomized, double-blind, placebo-controlled clinical trial – involved 25 adults with slightly elevated fasting uric acid levels.
Participants consumed a dose of concentrated Montmorency tart cherry powder (CherryPURE®) together with a purine-rich meal, in order to assess potential effects on blood glucose and inflammation.
The results showed no significant effect on postprandial uric acid levels, but a 4.2% reduction in post-meal blood glucose compared to placebo was observed, along with slight changes in the levels of certain inflammatory cytokines.
The second study, also randomized and placebo-controlled, used a standardized European tart cherry extract (NordicCherry®).
Ten healthy subjects took 500 mg per day of the extract for four weeks.
At the end of the intervention, a significant reduction of 37.4% in urate levels and a 23% decrease in C-reactive protein (CRP), a biomarker of systemic inflammation, were observed.
According to the researchers, regular intake of the extract showed a tangible impact on reducing inflammation and regulating uric acid metabolism, suggesting a potential role for tart cherries in the prevention of chronic inflammation and the promotion of metabolic health.
While the first study suggests modest and limited effects, the second provides stronger evidence in support of tart cherries as a functional ingredient capable of contributing to systemic well-being, even in healthy individuals.
Thanks to their polyphenol content, tart cherries are confirmed not only as beneficial for physical recovery, but also as a promising daily support in the prevention of mild inflammatory and metabolic conditions.
A natural ally for those who view nutrition as a key to long-term health.
Source: www.supplysidesj.com
Image source: Onlymyhealth.com
15 Dec 2023
Lorena Pinto, Product Manager of A.N.A. Chile Cherries, emphasised that the collaboration with the University is a scenario to present a wide range of fruit varieties that are now experiencing an unusual season due to climatic problems.
06 Jun 2024
The aim of this renewal is to adapt the visual identity of the PDO to an increasingly digital world. The Regulatory Council renews the corporate image by launching a new logo, representing both cherries and PDO picotas.
04 May 2026
In France, the first Royal Tioga cherries reach the shelves as early as April thanks to protective systems against wind and rain. Early production reduces competition, improves growers’ margins and allows prices of up to €14 per kilo at the start of the season.
04 May 2026
In 2026, UK sweet cherries confirm growth, quality gains and steady retail demand. With production forecast at 8,000 tonnes, the key challenge will be diversifying across retail, wholesale and export to capture value during seasonal peaks while reducing waste and big discounting.
